Trial · NCT01706198
Results by group106
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 106
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants Who Have Either an Asthma Control Test (ACT) Total Score of >=20 or an Increase From Baseline of >=3 in ACT Total Score at Week 24. | Usual Care | 56 | Percentage of participants | ||
| Percentage of Participants Who Have Either an Asthma Control Test (ACT) Total Score of >=20 or an Increase From Baseline of >=3 in ACT Total Score at Week 24. | FF/VI | 71 | Percentage of participants | ||
| Percentage of Participants Who Have Either an ACT Total Score of >=20 or an Increase From Baseline of >=3 in ACT Total Score at Weeks 12, 40 and 52. | Usual Care | Week 12, n=2032, 2009 | 62 | Percentage of participants | |
| Percentage of Participants Who Have Either an ACT Total Score of >=20 or an Increase From Baseline of >=3 in ACT Total Score at Weeks 12, 40 and 52. | FF/VI | Week 12, n=2032, 2009 | 75 | Percentage of participants | |
| Percentage of Participants Who Have Either an ACT Total Score of >=20 or an Increase From Baseline of >=3 in ACT Total Score at Weeks 12, 40 and 52. | Usual Care | Week 40, n=1938, 1904 | 60 | Percentage of participants | |
| Percentage of Participants Who Have Either an ACT Total Score of >=20 or an Increase From Baseline of >=3 in ACT Total Score at Weeks 12, 40 and 52. | FF/VI | Week 40, n=1938, 1904 | 71 | Percentage of participants | |
| Percentage of Participants Who Have Either an ACT Total Score of >=20 or an Increase From Baseline of >=3 in ACT Total Score at Weeks 12, 40 and 52. | Usual Care | Week 52, n=1922, 1896 | 58 | Percentage of participants | |
| Percentage of Participants Who Have Either an ACT Total Score of >=20 or an Increase From Baseline of >=3 in ACT Total Score at Weeks 12, 40 and 52. | FF/VI | Week 52, n=1922, 1896 | 70 | Percentage of participants | |
| Percentage of Participants With Asthma Control (ACT Total Score >=20) at Weeks 12, 24, 40 and 52. | Usual Care | Week 12, n=2032, 2009 | 46 | Percentage of participants | |
| Percentage of Participants With Asthma Control (ACT Total Score >=20) at Weeks 12, 24, 40 and 52. | FF/VI | Week 12, n=2032, 2009 | 61 | Percentage of participants | |
| Percentage of Participants With Asthma Control (ACT Total Score >=20) at Weeks 12, 24, 40 and 52. | Usual Care | Week 24, n=1957, 1936 | 46 | Percentage of participants | |
| Percentage of Participants With Asthma Control (ACT Total Score >=20) at Weeks 12, 24, 40 and 52. | FF/VI | Week 24, n=1957, 1936 | 60 | Percentage of participants | |
| Percentage of Participants With Asthma Control (ACT Total Score >=20) at Weeks 12, 24, 40 and 52. | Usual Care | Week 40, n=1938, 1904 | 45 | Percentage of participants | |
| Percentage of Participants With Asthma Control (ACT Total Score >=20) at Weeks 12, 24, 40 and 52. | FF/VI | Week 40, n=1938, 1904 | 58 | Percentage of participants | |
| Percentage of Participants With Asthma Control (ACT Total Score >=20) at Weeks 12, 24, 40 and 52. | Usual Care | Week 52, n=1922, 1896 | 44 | Percentage of participants | |
| Percentage of Participants With Asthma Control (ACT Total Score >=20) at Weeks 12, 24, 40 and 52. | FF/VI | Week 52, n=1922, 1896 | 58 | Percentage of participants | |
| Percentage of Participants Who Have an Increase From Baseline of >=3 in ACT Total Score at Weeks 12, 24, 40 and 52. | Usual Care | Week 12, n=2032, 2009 | 39 | Percentage of participants | |
| Percentage of Participants Who Have an Increase From Baseline of >=3 in ACT Total Score at Weeks 12, 24, 40 and 52. | FF/VI | Week 12, n=2032, 2009 | 55 | Percentage of participants | |
| Percentage of Participants Who Have an Increase From Baseline of >=3 in ACT Total Score at Weeks 12, 24, 40 and 52. | Usual Care | Week 24, n=1957, 1936 | 40 | Percentage of participants | |
| Percentage of Participants Who Have an Increase From Baseline of >=3 in ACT Total Score at Weeks 12, 24, 40 and 52. | FF/VI | Week 24, n=1957, 1936 | 54 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01706198/results